In times of economic recession, what are the rich to do with all their money? Why, make rock-solid investments in mega-companies such as Resident Evil’s Umbrella Corporation, of course! Fret not, ninety-nine-percenters, with Umbrella’s new IPO, even you can afford a piece of the Umbrella for a paltry $25. Starting September 14th, the company behind such remarkable drugs as Adravil®, Regenerate® and Return® will begin trading on Nasdaq.
Coincidentally, Resident Evil: Retribution, directed by Paul W.S. Anderson and starring Milla Jovovich, opens in theaters that very same day! Hit the jump to see how you can buy into the hype or even be employed by the Umbrella Corporation itself.
News of Umbrella’s IPO comes via their corporate website. Here’s the press release:
LOS ANGELES, September 4, 2012 – The Umbrella Corporation announced today that it has filed with the Global Exchange and Securities Commission for a proposed initial public offering of its common stock – ($500,000,000) shares at $25 per share. Shares are expected to begin trading on the Nasdaq Global Select Market on September 14, 2012 under the symbol “BLIFE.”
The altruistic mandate behind the IPO launch is to increase funding to allow for expansion of The Umbrella Corporation’s global infrastructure, with the goal of offering all shareholders a unique opportunity to be part of the corporation’s life changing developments. The IPO offering follows the phase one reorganization of company’s core communications including an extensive world recruitment tour in April, 2012 of its state-of-the-art Mobile Recruitment Center, which resulted in thousands of new recruits. This was followed by a phase two initiative, a global public relations outreach through its Facebook page in June 2012 resulting in an additional 300,000 new recruits. Phase three will see the launch of its revamped Umbrella Corporate website which will focus on the company’s corporate initiatives. (www.umbrellacorporation.net).
The Umbrella Corporation is involved in advanced research and development that includes clinical trials, scientific testing, and drug creation aimed at improving the health and condition of mankind and complete eradication of human suffering. In a groundbreaking move, as part of the stock purchase, shareholders will be sent free samples of the company’s latest breakthrough anti-aging drug.
Additionally, in this time of economic turmoil, The Umbrella Corporation will seek to shelter stockholders from the impending fiscal storm and provide coverage and stability for their families and themselves in a world made better by The Umbrella Corporation.
The Umbrella Corporation is proud to play an active part of the global solution, specifically in the areas of job creation and scientific advancement. The company is a biotech leader focused on the development of pharmaceuticals and technology designed for the betterment of all mankind. Our Business is Life Itself.
If you are interested in pursuing a journey of a lifetime with The Umbrella Corporation, please contact our specialized human resource managers.
Contact: The Umbrella Corporation
Facebook Page: https://www.facebook.com/umbrellacorp
The offering is being made through an underwriting group led by Global Private Bank Corporation and Biotech Giant Industries.
The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to this offering may be obtained from World Bank, 666 5th Avenue, Manhattan, NY 10022.
Want to work for Umbrella? Check out their recruitment videos below, courtesy of their Facebook page: